Filter News
Area of Research
News Topics
- (-) Buildings (2)
- (-) Summit (4)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (1)
- Artificial Intelligence (4)
- Big Data (1)
- Bioenergy (9)
- Biology (14)
- Biomedical (6)
- Biotechnology (3)
- Chemical Sciences (2)
- Clean Water (3)
- Climate Change (3)
- Computer Science (14)
- Coronavirus (2)
- Cybersecurity (1)
- Decarbonization (3)
- Energy Storage (5)
- Environment (21)
- Exascale Computing (2)
- Frontier (1)
- Fusion (1)
- Grid (1)
- High-Performance Computing (9)
- Isotopes (6)
- ITER (1)
- Materials (4)
- Materials Science (6)
- Mercury (3)
- Microscopy (3)
- Nanotechnology (3)
- National Security (4)
- Neutron Science (6)
- Nuclear Energy (4)
- Physics (2)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (4)
- Security (2)
- Space Exploration (1)
- Sustainable Energy (7)
- Transportation (6)
Media Contacts
Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country’s most complex research and technical challenges.
The daily traffic congestion along the streets and interstate lanes of Chattanooga could be headed the way of the horse and buggy with help from ORNL researchers.
Improved data, models and analyses from ORNL scientists and many other researchers in the latest global climate assessment report provide new levels of certainty about what the future holds for the planet
As the United States transitions to clean energy, the country has an ambitious goal: cut carbon dioxide emissions in half by the year 2030, if not before. One of the solutions to help meet this challenge is found at ORNL as part of the Better Plants Program.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.